| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/07/2006 | US7008753 Optical recording medium |
| 03/02/2006 | WO2006023844A2 Compositions and methods comprising proteinase activated receptor antagonists |
| 03/02/2006 | WO2006023783A1 Novel anthranilamides useful for controlling invertebrate pests |
| 03/02/2006 | WO2006023467A1 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Iϵ |
| 03/02/2006 | WO2006023462A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 03/02/2006 | WO2006023400A2 Chemical compounds |
| 03/02/2006 | WO2006022773A1 Gyrase inhibitors and uses thereof |
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006021544A1 2,4-di(aminophenyl) pyrimidines as plk inhibitors |
| 03/02/2006 | WO2006021533A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use |
| 03/02/2006 | WO2006021457A2 Pyrimidine derivatives |
| 03/02/2006 | WO2006021454A2 Pyrimidine derivatives |
| 03/02/2006 | WO2005123672A3 Kinase inhibitors |
| 03/02/2006 | WO2005075437A8 Pyridazinone derivatives and their use as pde4 inhibitors |
| 03/02/2006 | US20060047127 Sigma receptor inhibitors |
| 03/02/2006 | US20060047114 Azabicyclic amine histamine-3 receptor antagonists |
| 03/02/2006 | US20060046987 Substituted quinazoline derivatives and their use as inhibitors |
| 03/02/2006 | US20060046984 2-(3-acetamido-3-isobutyl-2-oxopyrrolidin-1-yl)-N-(3-(3,5-difluorophenyl)-1-hydroxy-1-(4-propoxypyrrolidin-2-yl)propan-2-yl)-4-phenylbutanamide; beta-amyloid peptide inhibitors; neurodegenerative diseases; Alzheimer's Disease, cerebral amyloid angiopathy and Down's Syndrome |
| 03/02/2006 | US20060046965 racemic mixtures, stereoisomers or optical isomers, useful as protease inhibitors; viricides |
| 03/02/2006 | US20060046596 Phthalimidylazo dyes, processess for the preparation thereof and the use thereof |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 03/02/2006 | CA2578122A1 Pyrimidine derivatives |
| 03/02/2006 | CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 03/02/2006 | CA2577782A1 Pyrrolo-naphthyl acids as pai-1 inhibitors |
| 03/02/2006 | CA2577251A1 Pyrimidine derivatives |
| 03/02/2006 | CA2577089A1 Sigma receptor inhibitors |
| 03/02/2006 | CA2577061A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 03/02/2006 | CA2576971A1 Compositions and methods comprising proteinase activated receptor antagonists |
| 03/02/2006 | CA2575670A1 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 03/02/2006 | CA2573371A1 Pyrimidines as plk inhibitors |
| 03/02/2006 | CA2573314A1 Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 03/02/2006 | CA2573310A1 Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 03/01/2006 | EP1628968A1 4-imidazolin-2-one compounds |
| 03/01/2006 | EP1628963A1 Novel ureido - and amido-pyrazolone derivatives |
| 03/01/2006 | EP1628957A1 Sulfopyrroles |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1628619A2 4-aminopyrimidine-5-one |
| 03/01/2006 | EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/01/2006 | EP1307192B1 Candesartan for treating migraine |
| 03/01/2006 | EP0842923B1 Pyrrole derivatives and medicinal composition |
| 03/01/2006 | CN1742007A Indole-derivative modulators of steroid hormone nuclear receptors |
| 03/01/2006 | CN1742005A Indolylmaleimide derivatives |
| 03/01/2006 | CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors |
| 03/01/2006 | CN1741995A Isoindoline derivative |
| 03/01/2006 | CN1740173A Inhibitors of interleukin-1beta converting enzyme |
| 03/01/2006 | CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1243752C Herbicidal heterocyclic compound |
| 03/01/2006 | CN1243750C 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 02/28/2006 | US7005444 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/28/2006 | US7005442 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 02/28/2006 | US7005439 Compounds |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005432 Central nervous system disorder; antidepressants; analgesics |
| 02/24/2006 | CA2533320A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2006 | WO2006021002A2 Compounds useful for inhibiting chk1 |
| 02/23/2006 | WO2006020916A2 Modulators of ppar and methods of their preparation |
| 02/23/2006 | WO2006020879A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | WO2006020598A2 Amido compounds and their use as pharmaceuticals |
| 02/23/2006 | WO2006019632A2 Cell adhesion inhibitors |
| 02/23/2006 | WO2006018443A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/23/2006 | WO2006018284A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | WO2006018260A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h 3 receptor |
| 02/23/2006 | WO2005123688A3 3-aminoindazoles |
| 02/23/2006 | WO2005115145A3 Quinone substituted quinazoline and quinoline kinase inhibitors |
| 02/23/2006 | WO2005053614A3 Advanced indolinone based protein kinase inhibitors |
| 02/23/2006 | US20060041143 Method for synthesis of 5-(3-pyridylmethylene-)imidazolidine-2,4-dione |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041137 Kinase inhibitors |
| 02/23/2006 | US20060041135 Such as (S)-5-(1-methylpyrrolidin-2-yl)pyridine-3-carbaldehyde; intermediates; for modulation of nicotinic acetylcholinic receptors |
| 02/23/2006 | US20060041126 Electroluminescent device |
| 02/23/2006 | US20060041034 Polyoxo derivatives of bis(pyrimidinylidene)-, bis(indanylidene)-, bis(dioxanylidene)- and bis(pyrazolylidene)- condensates of bisisoindolylidenes, e.g., 3,3'-Bis(1,3-dioxoindan-2-ylidene)-[1,1']biisoindolylidene and 3,3'-Bis(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5-ylidene)-[1,1']biisoindolylidene |
| 02/23/2006 | US20060041006 PDE4B inhibitors and uses therefor |
| 02/23/2006 | US20060040994 Substituted amide beta secretase inhibitors |
| 02/23/2006 | US20060040986 Erythropoietin production accelerator |
| 02/23/2006 | US20060040982 2-(5-aminocarbonyl-1H-imidazol-4-ylamino)-8-chloroquinoline; inhibit the IgE receptor signaling cascade; inhibit degranulation of mast and/or basophil cells; allergies; scleroderma, increased fibrosis, keloids, post-surgical scars, pulmonary fibrosis, vascular spasms, migraine, reperfusion injury |
| 02/23/2006 | US20060040978 5-HT7 receptor antagonists |
| 02/23/2006 | US20060040973 Novel guanidine mimics as factor Xa inhibitors |
| 02/23/2006 | US20060040968 2-(Amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040950 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/23/2006 | US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example |
| 02/23/2006 | US20060040947 inflammation; N-(4-Phenylpyridin-2-yl)isoquinolin-5-amine; analgesis; antinociceptive agents |
| 02/23/2006 | US20060040941 7-Aminoimidazotriazones |
| 02/23/2006 | US20060040937 N-aroyl cyclic amines as orexin receptor antagonists |
| 02/23/2006 | US20060040923 1,1-Diethyl-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea; respiratory syncytial virus; cost efficient replacement for Synagis (palivizumab) used for RSV; respiratory system disorders; asthna; viral diseases; myxoviruses; mumps; flaviviruses; dengue, West Nile, parainfluenza viruses |
| 02/23/2006 | US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders |
| 02/23/2006 | US20060040906 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | CA2577880A1 Compounds useful for inhibiting chk1 |
| 02/23/2006 | CA2575853A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | CA2575826A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | CA2575561A1 Amido compounds and their use as pharmaceuticals |
| 02/23/2006 | CA2573974A1 Tgf-.beta. gene expression inhibitor |
| 02/23/2006 | CA2573764A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 02/23/2006 | CA2573730A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
| 02/23/2006 | CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents |